Research programme: delta opioid receptor antagonist - Southern Research Institute/Ernest Gallo Clinic and Research Center

Drug Profile

Research programme: delta opioid receptor antagonist - Southern Research Institute/Ernest Gallo Clinic and Research Center

Alternative Names: SoRI-9409

Latest Information Update: 16 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Southern Research Institute
  • Developer Ernest Gallo Clinic and Research Center; Southern Research Institute
  • Class Morphine derivatives
  • Mechanism of Action Opioid delta receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Alcoholism

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in Alcoholism in USA
  • 11 Sep 2008 Pharmacodynamics data from a preclinical trial in Alcoholism released by Southern Research Institute
  • 11 Sep 2008 Preclinical trials in Alcoholism in USA (Intraperitoneal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top